Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Deneka AY"'
Autor:
Nikonova AS; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA., Deneka AY; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA., Silva FN; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular & Cell Biology & Genetics (MCBG) Program, Drexel University College of Medicine, Philadelphia, PA, USA., Pirestani S; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular & Cell Biology & Genetics (MCBG) Program, Drexel University College of Medicine, Philadelphia, PA, USA., Tricarico R; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA.; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy., Kiseleva AA; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA., Zhou Y; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA., Nicolas E; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA., Flieder DB; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA., Grivennikov SI; Departments of Medicine and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Golemis EA; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, USA. Erica.Golemis@fccc.edu.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. Erica.Golemis@fccc.edu.
Publikováno v:
Oncogenesis [Oncogenesis] 2023 Aug 05; Vol. 12 (1), pp. 40. Date of Electronic Publication: 2023 Aug 05.
Autor:
Ogier C, Solomon AMC, Lu Z, Recoules L, Klochkova A, Gabitova-Cornell L, Bayarmagnai B, Restifo D, Surumbayeva A, Vendramini-Costa DB, Deneka AY, Francescone R, Lilly AC, Sipman A, Gardiner JC, Luong T, Franco-Barraza J, Ibeme N, Cai KQ, Einarson MB, Nicolas E, Efimov A, Megill E, Snyder NW, Bousquet C, Cros J, Zhou Y, Golemis EA, Gligorijevic B, Soboloff J, Fuchs SY, Cukierman E, Astsaturov I
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 17. Date of Electronic Publication: 2023 Sep 17.
Autor:
Tikhomirova M; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia., Topchu I; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.; Feinberg School of Medicine, Northwestern University, Chicago, IL 60610, USA., Mazitova A; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.; Department of Medicine and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Barmin V; Moscow P.A. Gertsen Oncological Research Institute, 125284 Moscow, Russia., Ratner E; Republican M.Z.Sigal Clinical Oncology Hospital, 420029 Kazan, Russia., Sabirov A; Republican M.Z.Sigal Clinical Oncology Hospital, 420029 Kazan, Russia., Abramova Z; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia., Deneka AY; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 May 20; Vol. 14 (10). Date of Electronic Publication: 2022 May 20.
Autor:
Deneka AY; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Baca Y; Caris Life Sciences, Phoenix, Arizona., Serebriiskii IG; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Kazan Federal University, Kazan, Russia., Nicolas E; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Parker MI; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Drexel University College of Medicine, Philadelphia, Pennsylvania., Nguyen TT; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Drexel University College of Medicine, Philadelphia, Pennsylvania., Xiu J; Caris Life Sciences, Phoenix, Arizona., Korn WM; Caris Life Sciences, Phoenix, Arizona., Demeure MJ; Precision Medicine Program, Hoag Family Cancer Institute, Newport Beach, California., Wise-Draper T; Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati, Cincinnati, Ohio., Sukari A; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan., Burtness B; Section of Medical Oncology, Department of Internal Medicine, and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Golemis EA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Lewis Katz School of Medicine, Department of Cancer and Cellular Biology, Philadelphia, Pennsylvania.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1925-1937.
Autor:
Deneka AY; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Nikonova AS; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Lee HO; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Kruger WD; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Golemis EA; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. Erica.Golemis@fccc.edu.; Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 19140, USA. Erica.Golemis@fccc.edu.
Publikováno v:
Oncogenesis [Oncogenesis] 2022 Apr 11; Vol. 11 (1), pp. 15. Date of Electronic Publication: 2022 Apr 11.
Autor:
Sun D; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Institute of Life Sciences, Jiangsu University, Jinkou District, Zhenjiang, Jiangsu, China., Nikonova AS; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Zhang P; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Institute of Life Sciences, Jiangsu University, Jinkou District, Zhenjiang, Jiangsu, China., Deneka AY; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Fitzgerald ME; C4 Therapeutics, Inc., Watertown, Massachusetts., Michael RE; C4 Therapeutics, Inc., Watertown, Massachusetts., Lee L; C4 Therapeutics, Inc., Watertown, Massachusetts., Lilly AC; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Drexel University College of Medicine, Philadelphia, Pennsylvania., Fisher SL; C4 Therapeutics, Inc., Watertown, Massachusetts., Phillips AJ; C4 Therapeutics, Inc., Watertown, Massachusetts., Nasveschuk CG; C4 Therapeutics, Inc., Watertown, Massachusetts., Proia DA; C4 Therapeutics, Inc., Watertown, Massachusetts., Tu Z; Institute of Life Sciences, Jiangsu University, Jinkou District, Zhenjiang, Jiangsu, China. Erica.Golemis@fccc.edu zhigangtu@ujs.edu.cn., Golemis EA; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Erica.Golemis@fccc.edu zhigangtu@ujs.edu.cn.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Aug; Vol. 20 (8), pp. 1367-1377. Date of Electronic Publication: 2021 May 27.
Autor:
Deneka AY; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA.; Kazan Federal University, Kazan, Russian Federation, Kazan, Tatarstan, Russia., Kopp MC; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA.; Cancer Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania., Nikonova AS; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA., Gaponova AV; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA., Kiseleva AA; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA., Hensley HH; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA., Flieder DB; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA.; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Serebriiskii IG; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA., Golemis EA; Program in Molecular Therapeutics Fox Chase Cancer Center, Philadelphia, PA. Erica.Golemis@fccc.edu.
Publikováno v:
Cancer research [Cancer Res] 2021 Jul 01; Vol. 81 (13), pp. 3717-3726. Date of Electronic Publication: 2021 May 18.
Autor:
Deneka AY; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.; Department of Biochemistry and Biotechnology, Kazan Federal University, 420000 Kazan, Russia., Einarson MB; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA., Bennett J; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.; Department of Biology, Chestnut Hill College, Philadelphia, PA 19118, USA., Nikonova AS; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA., Elmekawy M; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.; Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia., Zhou Y; Bioinformatics and Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA., Lee JW; Section of Medical Oncology, Department of Internal Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA., Burtness BA; Section of Medical Oncology, Department of Internal Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA., Golemis EA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jan 28; Vol. 12 (2). Date of Electronic Publication: 2020 Jan 28.
Autor:
Jing, Jinzhong1 (AUTHOR), Wang, Jiayi1 (AUTHOR), Wu, Qian1 (AUTHOR), Yin, Shenggang1 (AUTHOR), He, Zhen1 (AUTHOR), Tang, Jiayong1 (AUTHOR), Jia, Gang1 (AUTHOR), Liu, Guangmang1 (AUTHOR), Chen, Xiaoling1 (AUTHOR), Tian, Gang1 (AUTHOR), Cai, Jingyi1 (AUTHOR), Kang, Bo2 (AUTHOR), Che, Lianqiang1 (AUTHOR), Zhao, Hua1 (AUTHOR) zhua666@126.com
Publikováno v:
Journal of Animal Science & Biotechnology. 7/8/2024, Vol. 15 Issue 1, p1-18. 18p.
Autor:
Deneka AY; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Alexander.Deneka@fccc.edu.; Department of Biochemistry, Kazan Federal University, 420000 Kazan, Russia. Alexander.Deneka@fccc.edu., Boumber Y; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.; Department of Biochemistry, Kazan Federal University, 420000 Kazan, Russia.; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA., Beck T; Cleveland Clinic, Cleveland, OH 44195, USA., Golemis EA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Erica.Golemis@fccc.edu.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Sep 03; Vol. 11 (9). Date of Electronic Publication: 2019 Sep 03.